Validation of the Monte Carlo simulator GATE for indium-111 imaging

被引:52
作者
Assié, K
Gardin, I
Véra, P
Buvat, I
机构
[1] CHU Pitie Salpetriere, INSERM, UMR 678, UPMC, F-75634 Paris, France
[2] Univ QUANT IF, Fac Med, F-76183 Rouen, France
[3] CHU Rouen, Dept Nucl Med, F-76000 Rouen, France
[4] Ctr Henri Becquerel, F-76000 Rouen, France
关键词
D O I
10.1088/0031-9155/50/13/010
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Monte Carlo simulations are useful for optimizing and assessing single photon emission computed tomography (SPECT) protocols, especially when aiming at measuring quantitative parameters from SPECT images. Before Monte Carlo simulated data can be trusted, the simulation model must be validated. The purpose of this work was to validate the use of GATE, a new Monte Carlo simulation platform based on GEANT4, for modelling indium-111 SPECT data, the quantification of which is of foremost importance for dosimetric studies. To that end, acquisitions of In-111 line sources in air and in water and of a cylindrical phantom were performed, together with the corresponding simulations. The simulation model included Monte Carlo modelling of the camera collimator and of a back-compartment accounting for photomultiplier tubes and associated electronics. Energy spectra, spatial resolution, sensitivity values, images and count profiles obtained for experimental and simulated data were compared. An excellent agreement was found between experimental and simulated energy spectra. For source-to-collimator distances varying from 0 to 20 cm, simulated and experimental spatial resolution differed by less than 2% in air, while the simulated sensitivity values were within 4% of the experimental values. The simulation of the cylindrical phantom closely reproduced the experimental data. These results suggest that GATE enables accurate simulation of In-111 SPECT acquisitions.
引用
收藏
页码:3113 / 3125
页数:13
相关论文
共 25 条
[1]   Monte Carlo simulation in PET and SPECT instrumentation using GATE [J].
Assié, K ;
Breton, V ;
Buvat, I ;
Comtat, C ;
Jan, S ;
Krieguer, M ;
Lazaro, D ;
Morel, C ;
Rey, M ;
Santin, G ;
Simon, L ;
Staelens, S ;
Strul, D ;
Vieira, JM ;
Van de Walle, R .
NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT, 2004, 527 (1-2) :180-189
[2]  
Bolch WE, 1999, J NUCL MED, V40, p11S
[3]  
Breton V, 2003, METHOD INFORM MED, V42, P143
[4]  
Chinn PC, 1999, INT J ONCOL, V15, P1017
[5]   Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA(0),D-Phe(1),Tyr(3)]octreotide, a promising somatostatin analogue for radionuclide therapy [J].
deJong, M ;
Bakker, WH ;
Krenning, EP ;
Breeman, WAP ;
vanderPluijm, ME ;
Bernard, BF ;
Visser, TJ ;
Jermann, E ;
Behe, M ;
Powell, P ;
Macke, HR .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1997, 24 (04) :368-371
[6]  
Dewaraja YK, 2000, J NUCL MED, V41, P1760
[7]   Treatment planning for radio-immunotherapy [J].
Erdi, AK ;
Erdi, YE ;
Yorke, ED ;
Wessels, BW .
PHYSICS IN MEDICINE AND BIOLOGY, 1996, 41 (10) :2009-2026
[8]   NEWER APPROACHES TO THE RADIOLABELING OF MONOCLONAL-ANTIBODIES BY USE OF METAL-CHELATES [J].
GANSOW, OA .
NUCLEAR MEDICINE AND BIOLOGY, 1991, 18 (04) :369-381
[9]   Voxeldose:: A computer program for 3-D dose calculation in therapeutic nuclear medicine [J].
Gardin, I ;
Bouchet, LG ;
Assié, K ;
Caron, J ;
Lisbona, A ;
Ferrer, L ;
Bolch, WE ;
Vera, P .
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2003, 18 (01) :109-115
[10]  
*GEANT4 COLL, 2002, SLACPUB9350 GEANT4 C